News
Our health care system needs to do a better job of diagnosing and supporting people with cannabis-related diseases,” a ...
President Trump just issued an executive order to rebalance the global pharmaceutical market — by tying U.S. drug prices to the artificially low, government-set prices in other developed nations.
Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...
The companies’ new effort would bypass traditional middlemen to cut the drug’s monthly cost from a list price of around $606 ...
Adam Colborn, JD, associate vice president of congressional affairs at AMCP, shares insights on the impact of the Most ...
Missourians simply cannot afford their prescription drugs. More than one in four have skipped doses or split pills to make prescriptions last longer. Over half worry they won’t be able to afford their ...
Navigating 2025 Drug Pricing Policies webinar, panelists discussed the Most Favored Nation executive order, bills aimed at ...
Food and Drug Administration Commissioner Marty Makary said his agency may fast-track new drugs from pharmaceutical companies that “equalize” the cost of their medicines between the US and other ...
FDA Commissioner Marty Makary suggests his agency may expedite drug reviews for manufacturers reducing U.S. prices to global ...
11d
Raw Story on MSNNew Trump threat poised to send medication prices soaringAt a cabinet meeting Tuesday, President Donald Trump floated the idea of imposing a 200% tariff rate on pharmaceuticals, ...
The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Biden-era ...
President Trump signed an executive order aiming to cut prescription drug costs by bringing the price the U.S. pays in line with comparable developed nations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results